A Study to Examine the Effect of Levodopa-Carbidopa Intestinal Gel (LCIG) Therapy Relative to That of Optimized Medical Treatment (OMT) on Non-motor Symptoms (NMS) Associated With Advanced Parkinson's Disease (PD)
Clinical trial NCT02549092 · COMPLETED
Trial details
- NCT number
- NCT02549092
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-26
- Primary completion
- 2020-05-14
- Enrollment
- 89
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.